https://scholars.lib.ntu.edu.tw/handle/123456789/553005
標題: | Incidence and impact of low-level viremia among people living with HIV who received protease inhibitor- or dolutegravir-based antiretroviral therapy | 作者: | Chen, Guan-Jhou HSIN-YUN SUN SUI-YUAN CHANG ARISTINE CHENG YU-SHAN HUANG YI-CHIA HUANG Su, Yi-Ching Liu, Wen-Chun Hung, Chien-Ching CHIEN-CHING HUNG |
關鍵字: | Genetic barrier; Integrase strand transfer inhibitor; Nucleoside reverse transcriptase inhibitor; Resistance-associated mutation; Virological failure | 公開日期: | 13-二月-2021 | 卷: | 105 | 來源出版物: | International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 摘要: | The impact of very low-level viremia (VLLV) and low-level viremia (LLV) are rarely investigated among people living with HIV (PLWH) receiving dolutegravir- vs protease inhibitor (PI)-based antiretroviral therapy (ART). |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/553005 | ISSN: | 12019712 | DOI: | 10.1016/j.ijid.2021.02.045 | SDG/關鍵字: | abacavir; atazanavir; darunavir; dolutegravir; lamivudine; lopinavir; nonnucleoside reverse transcriptase inhibitor; proteinase inhibitor; RNA directed DNA polymerase inhibitor; tenofovir disoproxil; virus RNA; zidovudine; antiretrovirus agent; dolutegravir; fused heterocyclic rings; integrase inhibitor; oxazine derivative; piperazine derivative; proteinase inhibitor; pyridone derivative; adult; antiretroviral therapy; antiviral resistance; Article; CD4 lymphocyte count; cohort analysis; controlled study; drug substitution; drug withdrawal; female; follow up; human; Human immunodeficiency virus infected patient; Human immunodeficiency virus infection; human tissue; incidence; major clinical study; male; metabolic syndrome X; observational study; retrospective study; risk factor; treatment duration; unspecified side effect; viremia; virus load; clinical trial; Human immunodeficiency virus infection; middle aged; viremia; virology; virus load; Adult; Anti-Retroviral Agents; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Integrase Inhibitors; Humans; Incidence; Male; Middle Aged; Oxazines; Piperazines; Protease Inhibitors; Pyridones; Viral Load; Viremia |
顯示於: | 醫學檢驗暨生物技術學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。